New Surgical Infection Society guidelines on the management of intra-abdominal infection

The Surgical Infection Society (SIS) presents new evidence-based guidelines for the management of intra-abdominal infection (IAI) in the peer-reviewed journal Surgical Infections. Click here to read the guidelines article now. 

“These guidelines are critical in the ongoing work by the Surgical Infection Society to decrease the number of deaths from the most common and severe infections that surgeons see: Infections of the abdomen,” says Surgical Infections Editor-in-Chief Robert G. Sawyer, MD, Dean and Professor of Surgery, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Mich. “Most importantly, these guidelines are applicable across the globe, fostering better outcomes worldwide.”

The guidelines are based on a systematic review of current literature and contain new recommendations and updates. Evidence-based recommendations were developed for antimicrobial agent selection, timing route of administration, duration, and de-escalation; timing of source control; treatment of specific pathogens; treatment of specific intra-abdominal disease processes; and implementation of hospital-based antimicrobial stewardship programs. 

About the Journal
Surgical Infections is a comprehensive and authoritative peer-reviewed journal dedicated to the biology, prevention, and management of post-operative infections. Published eight times per year in print and online, the Journal delivers original articles covering the latest advances, new therapeutic management strategies, and translational research that is being applied to improve clinical outcomes and successfully treat post-operative infections. Surgical Infections is the Official Journal of the Surgical Infection Society (SIS), SIS-Europe, SIS-Latin America, and the Chinese Society of Surgical Infection and Intensive Care. For complete information and a sample issue, please visit the Surgical Infections website.

About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, public health and policy, and technology and engineering. For further information, please visit the Mary Ann Liebert, Inc. website.